EPB42 (Gene)

Synonyms:ENTREZ:2038, EPB42, HGNC:3381, MIM:177070, NM_000119, NM_001114134, NP_000110, NP_001107606, PA, SPH5, XM_005254225, XM_011521349, XM_011521350, XM_011521351, XM_011521352, XM_011521353, XM_011521354, XP_005254282, XP_011519651, XP_011519652, XP_011519653, XP_011519654, XP_011519655, XP_011519656, erythrocyte membrane protein band 4.2
Omim:OMIM:177070
Id:ENSG00000166947
Hgnc:HGNC:3381
Entrez:2038
Description:erythrocyte membrane protein band 4.2
Erythrocyte membrane protein band 4.2 is an ATP-binding protein which may regulate the association of protein 3 with ankyrin. It probably has a role in erythrocyte shape and mechanical property regulation. Mutations in the EPB42 gene are associated with recessive spherocytic elliptocytosis and recessively transmitted hereditary hemolytic anemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View EPB42's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with EPB42.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using EPB42.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for EPB42.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with EPB42.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.